Status:
RECRUITING
Gene x Environment Interplay in Developmental Dyslexia Treatment: A Round-trip Translation Between Humans and Animal
Lead Sponsor:
IRCCS Eugenio Medea
Collaborating Sponsors:
Università degli studi di Bergamo
Conditions:
Reading Disorder
Eligibility:
All Genders
5-6 years
Phase:
NA
Brief Summary
Developmental dyslexia affects 7% of school-age children (Male:Female ratio of 1.5:1) and incurs disadvantages in education and occupation. Scientific progress concerning the etiology of developmental...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- 5-years old pre-readers,
- normal intelligence quotient,
- no main counter indications for magnetic resonance acquisition,
- no previous diagnosis of any neurodevelopmental disorders.
- Exclusion Criteria:
- intelligence quotient below the average range,
- presence of counter indications for magnetic resonance acquisition,
- previous diagnosis of any neurodevelopmental disorders.
Exclusion
Key Trial Info
Start Date :
April 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06186882
Start Date
April 30 2023
End Date
April 30 2026
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scientific Institute IRCCS E Medea
Bosisio Parini, LC, Italy, 23842